These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9668588)

  • 1. Regulation of glucose disturbances with glibenclamide in patients with thalassemia.
    Ladis V; Theodorides C; Palamidou F; Frissiras S; Berdousi H; Kattamis C
    Ann N Y Acad Sci; 1998 Jun; 850():471-4. PubMed ID: 9668588
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose disturbances and regulation with glibenclamide in thalassemia.
    Ladis V; Theodorides C; Palamidou F; Frissiras S; Berdousi H; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():871-8. PubMed ID: 10091160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
    Gamberini MR; Fortini M; Gilli G; Testa MR; De Sanctis V
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():867-9. PubMed ID: 10091159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of diabetes in cystic fibrosis and thalassemia major.
    Holl RW; Buck C; Cario H; Wolf A; Thon A; Kohne E; Debatin KM
    Diabetes Care; 1998 Apr; 21(4):671-2. PubMed ID: 9571365
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycemic treatment: Control of glycemia.
    Bloomgarden ZT
    Diabetes Care; 2004 May; 27(5):1227-34. PubMed ID: 15111555
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major.
    Jones TW; Boulware SD; Caprio S; Merkel P; Amiel SA; Pearson HA; Sherwin RS; Tamborlane WV
    Pediatr Res; 1993 May; 33(5):497-500. PubMed ID: 8511023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose Homeostasis and Effect of Chelation on β Cell Function in Children With β-Thalassemia Major.
    Gomber S; Dabas A; Bagmar S; Madhu SV
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):56-59. PubMed ID: 29200160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
    Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors.
    Hafez M; Youssry I; El-Hamed FA; Ibrahim A
    Hemoglobin; 2009; 33(2):101-8. PubMed ID: 19373585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin, glibenclamide plus acarbose in diabetes mellitus?].
    Hauner H
    Dtsch Med Wochenschr; 1995 Nov; 120(46):1605. PubMed ID: 7588044
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection.
    Mowla A; Karimi M; Afrasiabi A; De Sanctis V
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-cell secretion in patients with thalassemia major].
    Massolo F; Forese S; Gallinelli A; Bergomi A; Cellini M; Iori G; Leoni S; Amarri S
    Minerva Pediatr; 1995 Mar; 47(3):57-64. PubMed ID: 7791713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose intolerance in patients with thalassemia major: insulin resistance and hyperproinsulinemia.
    Cario H; Holl RW; Kohne E
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():953-5. PubMed ID: 10091170
    [No Abstract]   [Full Text] [Related]  

  • 15. Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.
    Chan YM; Laffel LM
    Pediatr Diabetes; 2007 Aug; 8(4):235-8. PubMed ID: 17659066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic iron and glucose dysregulation in thalassemia major.
    Noetzli LJ; Mittelman SD; Watanabe RM; Coates TD; Wood JC
    Am J Hematol; 2012 Feb; 87(2):155-60. PubMed ID: 22120775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of octreotide on glucose and insulin levels in a patient with type 2 diabetes on glibenclamide.
    Lee PE; Meneilly GS
    Diabetes Metab; 1999 Sep; 25(4):347-9. PubMed ID: 10566126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal glucose tolerance in CF--when should we offer diabetes treatment?
    Moran A
    Pediatr Diabetes; 2009 May; 10(3):159-61. PubMed ID: 19422601
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
    Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
    Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia.
    Kattamis C; Ladis V; Tsoussis D; Kaloumenou I; Theodoridis C
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():267-71. PubMed ID: 16462709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.